Survival of patients with a new diagnosis of heart failure: a population based study
暂无分享,去创建一个
S G Thompson | D. Wood | D. Wood | M. Cowie | S. Thompson | G. Sutton | A. Coats | P. Poole-Wilson | A. Coats | M R Cowie | D A Wood | A J S Coats | V Suresh | P A Poole-Wilson | G C Sutton | V. Suresh | D. Wood
[1] M. Komajda,et al. Risk stratification in chronic heart failure. , 1998, European heart journal.
[2] R Gramiak,et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. , 1980, Circulation.
[3] W G Stevenson,et al. Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.
[4] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[5] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[6] S G Thompson,et al. Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.
[7] P. Rizzon,et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. , 1994, European heart journal.
[8] C Larizza,et al. Predictors of prognosis in patients awaiting heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] R. Shabetai,et al. Prediction of outcome in late-stage cardiomyopathy. , 1990, American heart journal.
[10] K. Bailey,et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.
[11] K. Rosen,et al. The natural course of alcoholic cardiomyopathy. , 1974, Annals of internal medicine.
[12] H. Eriksson. Heart failure: a growing public health problem , 1995, Journal of internal medicine.
[13] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[14] B. Massie,et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.
[15] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[16] B. Massie,et al. Survival of patients with congestive heart failure: past, present, and future prospects. , 1987, Circulation.
[17] J Keegan,et al. Predictors of prognosis in severe chronic heart failure. , 1992, American heart journal.
[18] F. Tristani,et al. Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.
[19] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[20] D. Collet. Modelling Survival Data in Medical Research , 2004 .
[21] J. Schwartz,et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.
[22] G. Fonarow,et al. Impact of left ventricular cavity size on survival in advanced heart failure. , 1993, The American journal of cardiology.
[23] H. Kuhn,et al. [The etiology, course and prognosis of dilated cardiomyopathy]. , 1982, Zeitschrift fur Kardiologie.
[24] B. Schneider. MANUAL of the international statistical classification of diseases, injuries, and causes of death. Addendum 1. Supplementary interpretations and instructions for coding causes of death. , 1953, Bulletin of the World Health Organization. Supplement.
[25] I Ford,et al. Mortality in heart failure: clinical variables of prognostic value. , 1987, British heart journal.
[26] K. Bailey,et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. , 1993, Mayo Clinic proceedings.
[27] M. Packer,et al. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.
[28] M. Moeschberger,et al. Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.
[29] David Collett. Modelling Survival Data in Medical Research , 1994 .
[30] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[31] L. Wilhelmsen,et al. Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. , 1987, European heart journal.
[32] L. Hatle,et al. Chronic myocardial disease. I. Clinical picture related to long-term prognosis. , 2009, Acta medica Scandinavica.
[33] M. Packer,et al. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. , 1984, The New England journal of medicine.
[34] V. Fuster,et al. The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.